Review capabilities & services
Study types reviewed
Phase IPhase IIPhase IIIBiologicsCell & gene therapyOncologyRare diseaseObservational
Review services
Protocol reviewInformed consent reviewAmendment reviewContinuing reviewSafety report reviewFull board review
Therapeutic-area experience
OncologyCell & gene therapyRare diseasesImmunology
Illustrative target turnaround by review type — confirm in your service agreement.
Initial protocol — full board28 d
Full board
Amendment review18 d
Expedited